Literature DB >> 17545370

Compliance with alarm limits for pulse oximetry in very preterm infants.

Luisa Clucas1, Lex W Doyle, Jennifer Dawson, Susan Donath, Peter G Davis.   

Abstract

OBJECTIVE: The objective of this study was to determine the rate of compliance with hospital guidelines for alarm limits for pulse oximetry in preterm infants on oxygen therapy.
METHODS: All infants admitted to the nurseries at the Royal Women's Hospital, Melbourne, Australia, with gestational age <32 weeks or birth weight <1500 g between August 2005 and February 2006 were eligible for inclusion. Data on the alarm limits set for infants on oxygen therapy were collected prospectively. The target saturation range recommended in written hospital guidelines was 88% to 92%, with alarm limits set at 85% and 94%.
RESULTS: Data were prospectively collected for 144 subjects with mean (SD) gestational age 29.3 (2.4) weeks and birth weight 1226 (354) g; 1073 alarm limits were collected when infants were on oxygen. The lower alarm limit was set correctly 91.1% of the time. In contrast, the upper alarm limit was set correctly only 23.3% of the time: 76.5% of the time it was too high, and 23.8% of the time it was set at 100%. Infants with an upper alarm limit set correctly on a particular day had a significantly lower birth weight, gestational age, postmenstrual age, and postnatal age than infants who had the upper alarm limit set too high. Use of assisted ventilation, higher inspired oxygen concentrations, and more frequent changes in inspired oxygen concentration were all associated with improved odds of having an appropriately set upper alarm limit.
CONCLUSIONS: This study suggests that current guidelines regarding the upper pulse oximeter alarm limit for infants receiving oxygen might be commonly exceeded, although compliance might be better for infants at higher risk of adverse outcomes. However, there might be less variation from guidelines for the lower alarm limit.

Entities:  

Mesh:

Year:  2007        PMID: 17545370     DOI: 10.1542/peds.2006-3099

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

1.  Maintaining optimal oxygen saturation in premature infants.

Authors:  Yoke Yen Lau; Yih Yann Tay; Varsha Atul Shah; Pisun Chang; Khuan Tai Loh
Journal:  Perm J       Date:  2011

Review 2.  Compliance in oxygen saturation targeting in preterm infants: a systematic review.

Authors:  Henriëtte A van Zanten; Ratna N G B Tan; Agnes van den Hoogen; Enrico Lopriore; Arjan B te Pas
Journal:  Eur J Pediatr       Date:  2015-10-14       Impact factor: 3.183

3.  Improving manual oxygen titration in preterm infants by training and guideline implementation.

Authors:  Henriëtte A van Zanten; Steffen C Pauws; Evelien C Beks; Ben J Stenson; Enrico Lopriore; Arjan B Te Pas
Journal:  Eur J Pediatr       Date:  2016-11-26       Impact factor: 3.183

4.  Implementing higher oxygen saturation targets reduced the impact of poor weight gain as a predictor for retinopathy of prematurity.

Authors:  Pia Lundgren; Anna-Lena Hård; Åsa Wilde; Chatarina Löfqvist; Lois E H Smith; Ann Hellström
Journal:  Acta Paediatr       Date:  2017-09-20       Impact factor: 2.299

Review 5.  Safe oxygen saturation targeting and monitoring in preterm infants: can we avoid hypoxia and hyperoxia?

Authors:  Augusto Sola; Sergio G Golombek; María Teresa Montes Bueno; Lourdes Lemus-Varela; Claudia Zuluaga; Fernando Domínguez; Hernando Baquero; Alejandro E Young Sarmiento; Diego Natta; Jose M Rodriguez Perez; Richard Deulofeut; Ana Quiroga; Gabriel Lara Flores; Mónica Morgues; Alfredo García-Alix Pérez; Bart Van Overmeire; Frank van Bel
Journal:  Acta Paediatr       Date:  2014-07-28       Impact factor: 2.299

6.  Usual Care and Informed Consent in Clinical Trials of Oxygen Management in Extremely Premature Infants.

Authors:  Irene Cortés-Puch; Robert A Wesley; Michael A Carome; Robert L Danner; Sidney M Wolfe; Charles Natanson
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.